Clear Pricing Helps You Choose the Right Treatment
Why Transparent Pricing Matters When Comparing Mounjaro or Wegovy
When deciding between Mounjaro or Wegovy, hidden fees from online pharmacies can significantly impact your treatment budget and choice. Many competitors advertise low medication prices but add separate consultation fees (£30-50), prescription charges (£15-25), and admin costs at checkout, making true cost comparisons impossible. EverydayMeds eliminates this confusion with all-inclusive pricing—our £79.99 starting price covers your complete clinical assessment, prescriber review, prescription generation, and temperature-controlled delivery.
This transparency becomes crucial when comparing long-term treatment costs for Mounjaro or Wegovy, as both require ongoing monthly prescriptions. While other pharmacies may charge consultation fees for each prescription renewal, our prices include everything needed for continuous treatment. You can calculate your actual monthly costs upfront, whether choosing Wegovy's maintenance dose at £209.99 or considering Mounjaro's pricing structure through other providers.
Comprehensive Wegovy Pricing Without Hidden Charges
Our complete Wegovy pricing structure demonstrates true cost transparency: starter dose 0.25mg costs £79.99, escalating through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to maintenance 2.4mg at £209.99. These prices include clinical assessment, prescriber review, prescription, and next-day delivery—no additional charges apply. New customers can use code FIRST40 at checkout, while returning customers benefit from code DOSE25.
Our bundle options provide supply convenience with upfront pricing: the Intro Duo (0.25mg & 0.5mg) costs £169.99 for your first two months, while the Ultimate Stability Trio provides three months of maintenance supply (2.4mg × 3) for £649.99. Unlike competitors who reveal bundle costs only at checkout, our pricing remains consistent from browsing through purchase completion, helping you budget accurately when comparing Mounjaro or Wegovy treatment costs.
Clinical Evidence Comparing Mounjaro or Wegovy Mechanisms
Understanding the clinical differences between Mounjaro or Wegovy helps inform your treatment choice alongside cost considerations. Wegovy contains semaglutide, a GLP-1 receptor agonist, while Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors in a dual-agonist approach. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved average weight loss of approximately 15% at 68 weeks (Wilding et al., NEJM, 2021).
Mounjaro's SURMOUNT trials demonstrated the potential benefits of dual-receptor targeting, though direct head-to-head comparisons between Mounjaro or Wegovy remain limited due to different trial designs and patient populations. Both medications require prescription-only access and must be used alongside a reduced-calorie diet and increased physical activity for optimal effectiveness within their licensed indications.
How Wegovy's GLP-1 Mechanism Supports Weight Management
Wegovy works as a GLP-1 receptor agonist, mimicking your body's natural incretin hormone to regulate appetite and food intake. When injected once weekly, semaglutide may help reduce appetite by acting on brain appetite centres, promoting feelings of fullness after smaller meals. This mechanism can support portion control and may reduce food cravings, particularly for high-calorie foods. The medication slows gastric emptying, extending satiety periods between meals. Clinical studies suggest these effects, combined with lifestyle modifications, can support significant weight management outcomes. However, individual responses vary, and Wegovy represents one treatment option when comparing Mounjaro or Wegovy for your specific circumstances.
Streamlined Ordering Process for Either Treatment Option
Our transparent ordering process eliminates hidden fees while helping determine whether Mounjaro or Wegovy suits your needs best. Complete our 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our prescribers review your assessment within 3 working days (express 24-hour service available), evaluating suitability for either treatment based on clinical criteria. Once approved, your medication ships via next-day delivery using temperature-controlled packaging to maintain effectiveness. The entire process costs exactly what you see at checkout—no surprise consultation fees or administrative charges that other pharmacies often add during payment processing.
Storage and Practical Differences Between Treatment Options
When comparing Mounjaro or Wegovy practically, storage requirements may influence your choice, especially for travel or lifestyle flexibility. Wegovy requires refrigeration at 2-8°C but can remain at room temperature (below 30°C) for up to 6 weeks once removed from the fridge, providing greater travel convenience than Mounjaro's 21-day room temperature limit. Both use pre-filled injection pens, though Wegovy's FlexTouch pen design may feel different during administration. Dose escalation schedules differ slightly—Wegovy follows a structured 16-week escalation to maintenance, while Mounjaro uses a different timeline. Your prescriber can explain these practical differences when helping you choose between treatment options. Both medications require consistent weekly administration for optimal effectiveness within their licensed weight management indications.
Why Price Transparency Matters Most for Long-Term Treatment
Long-term weight management with either Mounjaro or Wegovy requires ongoing monthly prescriptions, making hidden fees particularly costly over time. While competitors may advertise low initial prices, their additional consultation fees (often £30-50 monthly), prescription charges, and processing fees can double your actual treatment costs. Our transparent pricing eliminates these surprise charges, with maintenance Wegovy costing exactly £209.99 monthly including everything needed for continued treatment.
This transparency becomes essential when budgeting for extended treatment periods, as clinical evidence suggests weight management benefits require ongoing medication use. The STEP 1 extension study showed patients regained approximately two-thirds of lost weight within one year of stopping treatment, highlighting the importance of sustainable, predictable pricing for long-term success. Our honest pricing structure supports informed decisions about treatment duration without fear of escalating hidden charges affecting your ability to continue therapy.
Expert Guidance for Your Treatment Choice
Choosing between Mounjaro or Wegovy requires clinical expertise considering your individual medical history, treatment goals, and practical preferences. Our GPhC-registered prescribers (#9012878) evaluate your suitability for either medication through comprehensive clinical assessment, discussing potential benefits and considerations specific to your circumstances. Both Wegovy and Mounjaro are available through EverydayMeds—your prescriber can help determine which treatment option aligns best with your needs. Start your assessment today using code FIRST40 for new customers, or DOSE25 for returning patients, and experience truly transparent pricing throughout your weight management journey. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment with complete price certainty.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
